Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001250853-18-000152)

Filing Details

Accession Number:: 0001250853-18-000152
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-11 20:34:24
Reporting Period:: 2018-12-07

Accepted Time:: 2018-12-11 20:34:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1335105	Lixte Biotechnology Holdings Inc.	LIXT.OB	Pharmaceutical Preparations (2834)	202903526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1369455	F Philip Palmedo	248 Route 25A, No. 2 East Setauket NY 11733		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-07	100,000	$0.50	1,100,000	No	4	P	Indirect	By Philip Palmedo L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Philip Palmedo L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2018-12-07	100,000	$0.50	100,000	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
100,000	2018-12-07	2022-12-07	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	66,020	Direct

Footnotes

The reporting person acquired 100,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50 per Unit.